Safety and Efficacy Study of Neovasculgen (Pl-VEGF165) Gene Therapy in Patients With Diabetic Foot

Clinical trial NCT02538705 · COMPLETED

Trial details

NCT number: NCT02538705
Sponsor: Artgen Biotech
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Ulcers Related to Diabetic Foot Syndrome

Start date: 2015-08-01
Primary completion: 2016-01-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.